At the time of writing, Jasper Therapeutics Inc [JSPR] stock is trading at $1.54, up 0.65%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The JSPR shares have gain 4.05% over the last week, with a monthly amount drifted -10.47%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Jasper Therapeutics Inc [NASDAQ: JSPR] stock has seen the most recent analyst activity on January 13, 2026, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $17. Previously, RBC Capital Mkts downgraded its rating to Sector Perform on July 08, 2025, and kept the price target unchanged to $5. On July 08, 2025, downgrade downgraded it’s rating to Market Perform but maintained its price target of $4 on the stock. William Blair downgraded its rating to a Mkt Perform. Cantor Fitzgerald downgraded its rating to a Neutral. UBS started tracking with a Buy rating for this stock on February 13, 2025, and assigned it a price target of $38. In a note dated December 06, 2024, BMO Capital Markets initiated an Outperform rating and provided a target price of $63 on this stock.
For the past year, the stock price of Jasper Therapeutics Inc fluctuated between $1.39 and $7.19. Currently, Wall Street analysts expect the stock to reach $41.67 within the next 12 months. Jasper Therapeutics Inc [NASDAQ: JSPR] shares were valued at $1.54 at the most recent close of the market. An investor can expect a potential return of 2605.84% based on the average JSPR price forecast.
Analyzing the JSPR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.58, Equity is -2.62 and Total Capital is -2.56. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Jasper Therapeutics Inc [NASDAQ:JSPR] has a current ratio of 2.59. As well, the Quick Ratio is 2.59, while the Cash Ratio is 2.42.
Transactions by insiders
Recent insider trading involved WIGGANS THOMAS G, Director, that happened on Sep 22 ’25 when 41000.0 shares were purchased. Director, Lucas Svetlana completed a deal on Sep 22 ’25 to buy 20000.0 shares. Meanwhile, President and CEO MARTELL RON bought 41000.0 shares on Sep 22 ’25.
